PACB
Pacific Biosciences of California, Inc. Healthcare - Medical Devices Investor Relations →
Pacific Biosciences of California, Inc. (PACB) closed at $1.82 as of 2026-02-02, trading 65.0% below its 200-week moving average of $5.20. This places PACB in the extreme value zone. The stock is currently moving closer to the line, down from -56.8% last week. The 14-week RSI sits at 43, indicating neutral momentum.
Over the past 749 weeks of data, PACB has crossed below its 200-week moving average 7 times. On average, these episodes lasted 73 weeks. Historically, investors who bought PACB at the start of these episodes saw an average one-year return of +6.1%.
With a market cap of $549 million, PACB is a small-cap stock. The company generates a free cash flow yield of 16.8%, which is notably high. Return on equity stands at -205.9%. The stock trades at 15.2x book value.
Share count has increased 33.2% over three years, indicating dilution.
Over the past 14.4 years, a hypothetical investment of $100 in PACB would have grown to $48, compared to $709 for the S&P 500. PACB has returned -4.9% annualized vs 14.6% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: PACB vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After PACB Crosses Below the Line?
Across 7 historical episodes, buying PACB when it crossed below its 200-week moving average produced an average return of -3.1% after 12 months (median +7.0%), compared to +11.4% for the S&P 500 over the same periods. 57% of those episodes were profitable after one year. After 24 months, the average return was +105.3% vs +27.7% for the index.
Each line shows $100 invested at the moment PACB crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
PACB has crossed below its 200-week MA 7 times with an average 1-year return of +6.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Oct 2011 | Jan 2014 | 119 | 82.7% | -38.7% | -39.3% |
| Mar 2014 | Jun 2014 | 11 | 23.6% | +15.5% | -62.4% |
| Jul 2014 | Oct 2014 | 13 | 20.4% | +1.9% | -65.5% |
| Sep 2015 | Sep 2015 | 1 | 4.2% | +128.3% | -54.5% |
| Dec 2016 | Oct 2018 | 98 | 66.6% | -32.7% | -53.9% |
| Jul 2019 | Aug 2020 | 57 | 49.2% | -37.4% | -69.4% |
| Jan 2022 | Ongoing | 212+ | 90.8% | Ongoing | -81.9% |
| Average | 73 | — | +6.1% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02